Announcements Trials
Browse Landscape

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Esophageal Neoplasms 5Barrett Esophagus 3Pancreatic Neoplasms 2Neoplasms 2Lung Neoplasms 2Stomach Neoplasms 1Liver Neoplasms 1Liver Cirrhosis 1Fibrosis 1Colorectal Neoplasms 1Carcinoma, Hepatocellular 1Carcinoma 1Breath Test 1Adenocarcinoma Of Esophagus 1

Interventions

Gemcitabine 406Oxaliplatin 131Fluorouracil 125130-nm albumin-bound paclitaxel 108Capecitabine 100Albumin-Bound Paclitaxel 90Leucovorin 88Irinotecan 87Radiotherapy 76Radiosurgery 64Taxes 63Cisplatin 56Erlotinib Hydrochloride 44Drug Therapy 42folfirinox 40Magnetic Resonance Spectroscopy 39pembrolizumab 35Blood Specimen Collection 33S 1 (combination) 31Pancreaticoduodenectomy 31Docetaxel 31Nivolumab 30Bevacizumab 30Biopsy 26Surgical Procedures, Operative 25Cyclophosphamide 25irinotecan sucrosofate 24Specimen Handling 24Radiation 22Standard of Care 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Pancreatic Neoplasms × Breath Tests × Clear all
NCT07243262 2026-05-19

Volatile Organic Compound Assessment in Pancreatic Ductal Adenocarcinoma (VAPOR2)

Imperial College London

Recruiting
6,079 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT05727020 2026-05-18

VAPOR

Imperial College London

Recruiting
1,005 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡